| Role |
Name |
Disclosure |
Details |
| Author | Blanche P Alter, MD, MPH, Expert, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Warren Magnuson Clinical Center, National Institutes of Health | Nothing to disclose | Details | | Coauthor | Jeffrey M Lipton, MD, PhD, Professor of Pediatrics, Albert Einstein College of Medicine; Director of Hematology-Oncology and Stem Cell Transplantation, Children's Health Network, North Shore/Long Island Jewish Health System; Chief, Hematology-Oncology and Stem Cell Transplantation, Schneider Children's Hospital | Nothing to disclose | Details | | Medical Editor | J Martin Johnston, MD, Director of Pediatric Hematology/Oncology, Backus Children's Hospital, Memorial Health University Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Steven K Bergstrom, MD, Assistant to the Chairman, Department of Pediatrics, Division of Hematology-Oncology, Kaiser Permanente Medical Center of Oakland | Nothing to disclose | Details | | CME Editor | Samuel Gross, MD, Professor Emeritus, Department of Pediatrics, University of Florida, Clinical Professor, Department of Pediatrics, UNC, Adjunct Professor, Department of Pediatrics, Duke University | Nothing to disclose | Details | | Chief Editor | Max J Coppes, MD, PhD, MBA, Executive Director, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Professor of Medicine, Oncology, and Pediatrics, Georgetown University | Nothing to disclose | Details |
|